HSE payments to pharma firms rise
New figures show that three units of Irish-based drug giant United Drug received payments totalling over €112m from the HSE in 2013.
According to the HSE's statistical analysis for 2013 just published, the amount received by three of the pharma firm's Irish subsidiaries totalled €112.4m in 2013.
The payments to the United Drug firms make up over 25pc of the total amount of €442.2m paid out by the HSE to pharma firms in 2013 in 'high tech wholesale and manufacturer payments'.
The figures show United Drug Wholesale (Dublin) received €54m with United Drug PLC Limerick receiving €33.63m and United Drug PLC Ballina was in receipt of €24.7m in fees. The €442m represents a 15pc increase on the €385m paid out to pharma firms under the high tech scheme in 2013.
The top amount paid to one individual entity was €89m paid out to Abbvie Ltd that was spun out from Abbott.
Pfizer Ltd - which recently announced a decision reversing numbers it employs here - received €57m in 2013.